Isotonische Natriumchlorid-Lösung Deltamedica (Sodium Chloride)

The solution delivers sodium and chloride ions directly into the bloodstream, increasing extracellular osmolarity. This draws water into the vascular compartment, expanding plasma volume and normalizing serum electrolyte concentrations, which supports hemodynamic stability and cellular function.

The prescribed dose of Isotonische Natriumchlorid-Lösung Deltamedica is determined by the treating clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. The healthcare professional will calculate the appropriate volume and rate of infusion for each individual case.

Safety data for isotonic saline in pregnancy and lactation are limited. It may be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. The prescriber should evaluate each situation individually and discuss any concerns with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Isotonische Natriumchlorid-Lösung Deltamedica provides a simple, isotonic saline composition, making it suitable for general fluid and electrolyte replacement. Compared with balanced electrolyte solutions, it lacks additional buffers such as lactate or acetate, which may be preferred in specific metabolic conditions. Choice depends on clinical goals and patient needs.

The solution should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Before use, inspect the container for any particulate matter or discoloration, and ensure the vial or bag is within its expiry date.

Isotonische Natriumchlorid-Lösung Deltamedica is administered intravenously. The prescriber determines the infusion rate and total volume based on the patient’s condition. Administration should follow aseptic technique, using appropriate IV sets, and the infusion should be monitored for signs of fluid overload or adverse reactions.

Serious risks include fluid overload leading to pulmonary edema, severe hypernatremia or hyperchloremia, and rare allergic or anaphylactoid reactions. Clinicians should monitor vital signs, fluid balance, and electrolyte levels closely, especially in patients with cardiac, renal, or hepatic impairment.

Patients with known hypersensitivity to sodium chloride or any component of the formulation should avoid use. Additionally, individuals with uncontrolled congestive heart failure, severe renal impairment, or conditions predisposing them to fluid overload should be evaluated carefully before administration.